Add Company
Join Now

Metaclipse Therapeutics Corporation Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Metaclipse Therapeutics Corporation's estimated annual revenue is currently $542.5k per year.(i)
  • Metaclipse Therapeutics Corporation's estimated revenue per employee is $77,500

Employee Data

  • Metaclipse Therapeutics Corporation has 7 Employees.(i)
  • Metaclipse Therapeutics Corporation grew their employee count by -30% last year.

Metaclipse Therapeutics Corporation's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Director Product DevelopmentReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Laboratory DirectorReveal Email/Phone
6
Senior ScientistReveal Email/Phone
7
PRESIDENT/ CEOReveal Email/Phone
8
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$1.7M11-8%N/AN/A
#3
$2.3M1550%N/AN/A
#4
$1.1M70%N/AN/A
#5
$17.1M1105%$0.07BN/A
#6
$4M26-7%N/AN/A
#7
$0.8M50%N/AN/A
#8
$1.1M717%N/AN/A
#9
$7.8M502%N/AN/A
#10
$1.7M1110%N/AN/A
Add Company

What Is Metaclipse Therapeutics Corporation?

Metaclipse Therapeutics is a preclinical stage biotech company developing novel cancer therapies that are tailored to each patient and their specific tumor. The Company’s first ‘personalized’ cancer therapy is for triple negative metastatic breast cancer. Metaclipse intends to commercialize its products through licensing agreements with major pharmaceutical companies after establishing their safety and effectiveness in early clinical trials by year-end 2019.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$542.5k

Revenue (est)

-30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M7N/AN/A
#2
$0.5M7N/AN/A
#3
$0.5M7N/AN/A
#4
$0.9M7N/AN/A
#5
$0.5M7N/AN/A